Polyphor axes staff as cash and options dwindle
Polyphor’s restructuring is beginning.
The Swiss biotech, once a darling of the country’s public markets, announced that it was laying off “up to” 29 employees …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
